Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Jun 3, 2020
HPV vaccine manufacturers commit to provide enough supply to immunise at least 84 million girls in Gavi countries
Learn More
Feb 8, 2022
CEPI, Shanghai Zerun Biotech and Walvax Biotech expand collaboration to develop COVID-19 multi-variant vaccine
Learn More
Feb 7, 2022
Walvax and Abogen Announce Safety and Immunogenicity Data from Phase 1 Clinical Study of AWcorna (SARS-CoV-2 mRNA Vaccine) Published in The Lancet Microbe
Learn More